Q3 2022 Holdings
Filed 2022-11-10 | 109 holdings | $91.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmac Inc(BMRN) | COM | 09061G101 | $13.8M | 163,230 | 15.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $11.1M | 249,567 | 12.1% |
| Atricure Inc(ATRC) | COM | 04963C209 | $8.9M | 226,532 | 9.7% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $7.1M | 53,050 | 7.8% |
| Arcus Biosciences(RCUS) | COM | 03969F109 | $5.9M | 227,032 | 6.5% |
| Amylyx Pharmaceutic(AMLX) | COM | 03237H101 | $5.8M | 205,400 | 6.3% |
| Boston Scientific(BSX) | COM | 101137107 | $4.9M | 126,976 | 5.4% |
| Alnylam Pharmacuetcl(ALNY) | COM | 02043Q107 | $4.5M | 22,680 | 4.9% |
| Arcutis Biotherape(ARQT) | COM | 03969K108 | $4.2M | 220,985 | 4.6% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $4.0M | 83,450 | 4.4% |
| Centene Corp del(CNC) | COM | 15135B101 | $3.5M | 45,600 | 3.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $3.5M | 13,252 | 3.9% |
| Altimmune Inc(ALT) | COM | 02155H200 | $3.4M | 269,100 | 3.7% |
| Arrowhead Pharmaceut(ARWR) | COM | 04280A100 | $3.3M | 98,800 | 3.6% |
| Beam Therapeutics(BEAM) | COM | 07373V105 | $3.1M | 65,700 | 3.4% |
| Certara Inc(CERT) | COM | 15687V109 | $2.3M | 173,129 | 2.5% |
| Beigene Limited(ONC) | SPN ADR | 07725L102 | $779.0K | 5,780 | 0.8% |
| Argenx SE(ARGX) | SPN ADR | 04016X101 | $448.0K | 1,270 | 0.5% |
| Biontech SE(BNTX) | SPN ADR | 09075V102 | $364.0K | 2,700 | 0.4% |
| Ascendis Pharma A S(ASND) | SPN ADR | 04351P101 | $195.0K | 1,890 | 0.2% |
| Unitedhealth GRP Inc(UNH) | COM | 91324P102 | $16.7K | 33,125 | 0.0% |
| Healthequity Inc(HQY) | COM | 42226A107 | $15.7K | 233,100 | 0.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $13.4K | 372,142 | 0.0% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $13.2K | 182,293 | 0.0% |
| Irhythm Technologies(IRTC) | COM | 450056106 | $12.9K | 102,911 | 0.0% |
| R1 RCM Inc(RCM1USD) | COM | 77634L105 | $12.6K | 682,594 | 0.0% |
| PTC Therapeutics I(PTCT) | COM | 69366J200 | $12.0K | 238,891 | 0.0% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $11.1K | 67,850 | 0.0% |
| Insmed Inc(INSM) | COM | 457669307 | $11.1K | 514,092 | 0.0% |
| Icon PLC(ICLR) | SHS | G4705A100 | $9.9K | 53,925 | 0.0% |
| Privia Health Group(PRVA) | COM | 74276R102 | $9.3K | 273,200 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $8.7K | 553,375 | 0.0% |
| Syneos Health Inc(8IN) | CL A | 87166B102 | $8.6K | 182,856 | 0.0% |
| Apellis Pharmaceutic(APLS) | COM | 03753U106 | $8.5K | 123,990 | 0.0% |
| Shockwave Medical(SWAVUSD) | COM | 82489T104 | $8.2K | 29,600 | 0.0% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $8.1K | 115,687 | 0.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $8.1K | 114,296 | 0.0% |
| Agiliti Inc | COM | 00848J104 | $8.0K | 557,747 | 0.0% |
| Denali Therapeutics(DNLI) | COM | 24823R105 | $7.5K | 243,350 | 0.0% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $7.4K | 41,800 | 0.0% |
| Blueprint Medicines(2L9) | COM | 09627Y109 | $7.2K | 109,900 | 0.0% |
| Bellus Health Inc(BLU) | COM NEW | 07987C204 | $6.5K | 614,429 | 0.0% |
| Cincor Pharma Inc | COM | 17240Y109 | $6.4K | 195,534 | 0.0% |
| Travere Therapeutics(TVTX) | COM | 89422G107 | $6.2K | 249,700 | 0.0% |
| Prometheus Bioscienc | COM | 74349U108 | $6.1K | 103,210 | 0.0% |
| Amicus Therapeutics(FOLD) | COM | 03152W109 | $6.0K | 572,682 | 0.0% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $6.0K | 18,415 | 0.0% |
| Horizon Therapeutics | SHS | G46188101 | $5.8K | 94,450 | 0.0% |
| Intra Cellular Thera(ITCIEUR) | COM | 46116X101 | $5.7K | 122,450 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $5.7K | 129,400 | 0.0% |